LifeStance Health Group, Inc.

LFST Healthcare Medical Care Facilities

LifeStance Health Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 13.9% from fiscal 2024.

Revenue
+25.3%
EPS
+2,042.9%
Free cash flow
+31.6%
Total debt
−5.15%

Quarter to September 2026, against a year earlier

13.44 0.77 −5.42%
Market cap
$5.1B
P/E
70.7×
Fwd P/E
81.1×
Dividend yield
—
F-score
8/9
Altman Z
2.65
Beneish M
−2.96
Dividend safety
n/a

LifeStance Health Group, Inc. (LFST) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, LifeStance Health Group, Inc. (LFST) trades at a P/B ratio of 3.4×. Over the past ten years it has ranged from 1.0× (August 2025) to 9.2× (June 2021); the current reading is higher than 97% of that period. That is above the Medical Care Facilities industry median of 3.1× and above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 1.8× (7.53%)
FY2024 1.9× (4.89%)
FY2023 2.0× 86.75%
FY2022 1.1× (46.10%)
FY2021 2.0× (71.23%)
FY2020 7.0× 0.00%
FY2019 7.0× —

Quarterly newest first

Period P/B ratio Change
Sep 2026 3.1× 10.51%
Jun 2026 2.8× 66.54%
Mar 2026 1.7× (6.55%)
Dec 2025 1.8× 25.31%
23 more quarters

Against its own ten years

Low 1.0× High 9.2×
Ten-year median 1.8×
Current reading's percentile 97

P/B ratio against peers

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on LFST